China Re: July 2026 Monthly Return Confirms Unchanged Share Base and 15.72% Public Float Compliance

Bulletin Express
Aug 06

China Reinsurance (Group) Corporation (China Re) filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, indicating a stable share structure with no movements in either authorised/registered capital or issued shares.

Key takeaways:

• Registered share capital steady at RMB 42.48 billion – H shares: 6.68 billion shares, par value RMB 1.00 each, totalling RMB 6.68 billion – Domestic shares: 35.80 billion shares, par value RMB 1.00 each, totalling RMB 35.80 billion

• Issued share capital unchanged – H shares (HKEX: 01508): 6.68 billion in issue; no treasury shares were held or cancelled during the month – Domestic shares: 35.80 billion in issue; no changes recorded

• No new share options, warrants, convertibles, or other equity-linked instruments were issued, and no other share movements occurred.

• Public-float confirmation – The company affirmed compliance with the minimum public-float requirement of 15.72%, a level previously approved by the Hong Kong Stock Exchange at listing.

The filing underscores China Re’s unchanged capital base and adherence to listing regulations, with Assistant President and Joint Company Secretary Cao Shunming providing the requisite board-level confirmations of compliance with all regulatory obligations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10